Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain. - Wikidata - awgldk - TriplyDB

Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.

Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.

http://www.wikidata.org/entity/Q37485507

about

The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.TMEM106B expression is reduced in Alzheimer's disease brains TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.What we know about TMEM106B in neurodegeneration.TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins.

P2860

Q24314869-BFC3F773-7004-4E6B-8ED5-F776BD37F5BE Q33729886-66316415-8CF2-406C-861E-E6F54F501003 Q33746240-D3AFE6BD-85DE-40E5-AC68-48446A7F8E9C Q36364206-5DE6EDE9-12E9-4273-A5C0-2C85A16DA8F3 Q37530270-32006E71-C356-44F2-8163-D063C37A741E Q38932474-AE483A14-06CF-4399-85FD-40D8444D8B45 Q55724715-28EE5BE4-DE82-491A-94C2-759D20739DC3

P2860

Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.

http://www.wikidata.org/entity/Q37485507

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@en

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@nl

type

label

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@en

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@nl

prefLabel

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@en

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@nl

P1433

Q37485507-03D7396A-8B8B-4FFA-B3CB-3253DBA99A53

P1476

Q37485507-7202974B-ED4D-44E3-B1B3-947554514BD1

P2093

Q37485507-064F2AEF-ADDC-4430-84CD-4063C11A01F8

Q37485507-2D9F85A1-24E7-4D3F-B1D1-41D8E5551F5A

Q37485507-8223AF9B-6077-47F7-9E5B-C16B034E35AB

Q37485507-ACD695D0-9DB6-4064-8EE2-CE98F4AC5DB8

Q37485507-AFB7250F-92F3-42BF-BA30-BC2E974F91DD

Q37485507-B0BEC7E0-935E-4C26-BE95-776764776184

Q37485507-BF609504-0D5F-4A50-8EC1-2181CD6BF427

P2860

Q37485507-08E98FF5-2F93-4453-A606-E1D253896D4F

Q37485507-0C69B014-FA46-4E01-95DD-FA10660ACE6A

Q37485507-12579D5C-BB1F-4A42-A6B2-6C087C1B0FD9

Q37485507-13019F9D-8406-4517-A400-1703DF63D525

Q37485507-1CB692BE-4DD6-4697-9D96-C624C50C159D

Q37485507-1E3088CE-3670-4D8D-821E-B45CFD0E8B7F

Q37485507-220DDC13-F756-40BE-A967-924E8064FD5A

Q37485507-2449BBAD-C38B-49CA-A412-71D4A1A99140

Q37485507-2D404877-6D5E-4553-9FE4-55094AAA9F48

Q37485507-2D638D7C-20C9-4B7C-A630-B80A311653EA

P2888

Q37485507-0F9B4AD4-71E3-4933-BCD3-E69E87B2232E

P304

Q37485507-656A7DD9-ABE1-4D5B-B26E-9FD2E071B47E

P31

Q37485507-CAC5657D-B0B4-4974-AAF1-AA1841BBF58D

P356

Q37485507-30547191-B5D8-4A12-8283-EEB7C9305ECF

P478

Q37485507-ED6F443D-2DAC-4C43-BBB5-18249C5DC096

P50

Q37485507-6B37885E-C9C3-4A80-B147-D1118962D6D3

Q37485507-C974E6DB-8C34-4CDD-B658-47B1537C9C60

P577

Q37485507-97626E3E-DE72-4DEB-82B9-BCE030EFC00C

P5875

Q37485507-2E333286-AFE5-4BE5-A6ED-B08B03C8DED1

P6179

Q37485507-2C1F9725-0D8F-42C1-B46F-163371EE9B01

P698

Q37485507-8ADBF040-23E1-4B90-8BBE-6B45AAA245F9

P932

Q37485507-FD0845C3-B498-4D57-8844-FB9C46214456

P356

P1433

Acta neuropathologica communications

P1476

Expression of TMEM106B, the fr ...... rmal and diseased human brain.

@en

P2093

Alice S Chen-Plotkin

http://www.w3.org/2001/XMLSchema#string

Emily Ashbridge

http://www.w3.org/2001/XMLSchema#string

Fenghua Hu

http://www.w3.org/2001/XMLSchema#string

Johanna I Busch

http://www.w3.org/2001/XMLSchema#string

Maria Martinez-Lage

http://www.w3.org/2001/XMLSchema#string

Virginia M Y Lee

http://www.w3.org/2001/XMLSchema#string

Vivianna M Van Deerlin

http://www.w3.org/2001/XMLSchema#string

P2860

A harmonized classification system for FTLD-TDP pathology

Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD

Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21

Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17

TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia

A genome-wide association study of global gene expression

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions.

P2888

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/2051-5960-1-36

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

John Q. Trojanowski

Murray Grossman

P577

2013-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

257885187

http://www.w3.org/2001/XMLSchema#string

P6179

1006086066

http://www.w3.org/2001/XMLSchema#string

P698

24252750

http://www.w3.org/2001/XMLSchema#string

P932

3893524

http://www.w3.org/2001/XMLSchema#string